Create
Query
event_store.db
—
signals
actions
approvals
artifacts
commitments
constraints
conversation_compaction
conversation_state
conversation_turns
dead_letters
decisions
deliveries
effects
email_messages
email_reply_drafts
email_threads
entities
entity_aliases
entity_tags
episode_context_index
episodes
event_subjects
events
events_archive
fact_sources
facts
inbox_items
inbox_links
jobs
leader_leases
links
memory_candidates
memory_embeddings
memory_items
memory_items_fts
(v)
memory_items_fts_config
memory_items_fts_data
memory_items_fts_idx
opportunity_memory
pending_interactions
proposal_sources
proposals
reminders
schedules
schema_migrations
signal_candidates
signal_fps
signals
sms_conversations
sms_messages
sms_reply_drafts
source_cursors
sources
sqlite_sequence
sqlite_stat1
stream_cursors
threads
watchers
Toggle helper tables
memory_items_fts_content
memory_items_fts_docsize
memory_items_fts_segdir
memory_items_fts_segments
memory_items_fts_stat
Structure
Content
Query
Insert
Drop
Import
Export
Update row sig_1244b4694937 in signals
id
sig_1244b4694937
Primary key.
TEXT
event_id
7216
TEXT NOT NULL
watcher_id
NULL
TEXT
signal_type
discovery_sec_filing_delta
TEXT NOT NULL
value
{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1601830/0001856094-26-000003.txt","as_of":"2026-04-09T03:12:49.786272+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1601830/0001856094-26-000003.txt","company":"RECURSION PHARMACEUTICALS, INC.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1601830/0001856094-26-000003.txt","article_chars":1675,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_068a1fc49125069c","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1601830/0001856094-26-000003.txt","content_type":"text/plain","enriched_at":"2026-04-09T19:13:38.065567+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1601830/0001856094-26-000003.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1601830/0001856094-26-000003.txt","source_event_id":"evt_c652e4f7b407","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"9387f60aca55d981","kind":"sec_filing","published_at":"20260408","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.72,"dates_mentioned":["2026-04-08","2026-04-07","2025-08-31","2014-03-05"],"entities":[{"asset_class":"equity","name":"Recursion Pharmaceuticals, Inc.","relevance":"high","symbol":"RXRX","type":"issuer"},{"asset_class":"person","name":"Blake Borgeson","relevance":"high","symbol":"","type":"reporting_owner"},{"asset_class":"other","name":"Rule 10b5-1 trading plan","relevance":"medium","symbol":"","type":"legal_framework"}],"event_type":"listing","information_gaps":["The extracted text does not clearly show the transaction type (e.g., buy/sell), number of shares, price per share, or total value; only partial numeric fragments appear (e.g., \u201c30000\u201d, \u201c3.10\u201d, \u201c6229863\u201d) without sufficient context to confirm what each represents.","No prior known state is provided in the prompt, so the \u201cwhat changed vs prior\u201d portion cannot be determined from the supplied text alone."],"key_facts":["SEC accession number: 0001856094-26-000003.","Form type: 4.","Issuer: RECURSION PHARMACEUTICALS, INC. (RXRX).","Reporting owner: Blake Borgeson.","Conformed period of report (transaction date): 2026-04-07.","Filed as of date: 2026-04-08.","The transaction is stated to be pursuant to a Rule 10b5-1 trading plan adopted on August 31, 2025.","The filing includes \u201cClass A Common Stock\u201d as the security referenced in the extracted text."],"numeric_claims":[{"label":"Filing date (as of)","value":"2026-04-08"},{"label":"Period of report (conformed)","value":"2026-04-07"},{"label":"Rule 10b5-1 plan adoption date","value":"2025-08-31"},{"label":"SEC accession number","value":"0001856094-26-000003"}],"primary_claim":"Form 4 for Recursion Pharmaceuticals, Inc. was filed on 2026-04-08 (covering period 2026-04-07) by reporting owner Blake Borgeson, and the transaction was pursuant to a Rule 10b5-1 trading plan adopted on August 31, 2025.","relevance_score":0.55,"sentiment":"neutral","source_quality":"medium","summary":"Recursion Pharmaceuticals, Inc. (RXRX) filed a Form 4 on 2026-04-08 covering a transaction dated 2026-04-07 by reporting owner Blake Borgeson. The filing states the trade was executed under a Rule 10b5-1 trading plan adopted on 2025-08-31.","topics":["SEC Form 4","insider trading","Rule 10b5-1","common stock transaction"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 RECURSION PHARMACEUTICALS, INC. \u00b7 Filed 20260408","ticker":"RXRX","tickers":["RXRX"],"title":"RXRX filed 4","url":"https://www.sec.gov/Archives/edgar/data/1601830/0001856094-26-000003.txt"}
TEXT NOT NULL
threshold
NULL
TEXT
direction
NULL
TEXT
severity
NULL
TEXT
window
NULL
TEXT
source
discovery_sec_filings
TEXT NOT NULL
reason_trace
{"_evidence_event_ids":["evt_c652e4f7b407"]}
TEXT
dedupe_key
signal_enriched:discovery_sec_filing_delta:e96e995edf53c8a7
TEXT NOT NULL
throttle_s
INTEGER (default 0
created_at
2026-04-09T03:12:49.786272+00:00
TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')
Update
Cancel